Physiology and consequences of lung hyperinflation in COPD

European Respiratory Review

Volumn 15, Issue 100, 2006, Pages 61-67

  O'Donnell, D E ^a,b   Laveneziana, P ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b NONE   (Canada)

Author keywords

Chronic obstructive pulmonary disease; Dynamic hyperinflation; Dyspnoea; Exercise; Lung volume; Respiratory mechanics

Indexed keywords

BREATHING MECHANICS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFERENCE PAPER; DISEASE EXACERBATION; EXPIRATORY FLOW; HUMAN; HYPERINFLATION; INSPIRATORY RESERVE VOLUME; LUNG CAPACITY; LUNG DEAD SPACE; LUNG HEMODYNAMICS; LUNG VENTILATION; LUNG VOLUME; PHYSICAL ACTIVITY; QUALITY OF LIFE; TIDAL VOLUME;

EID: 34447135516     PISSN: 09059180     EISSN: None     Source Type: Journal    
DOI: 10.1183/09059180.00010002     Document Type: Conference Paper

References (53)

1. O'Donnell DE, Webb KA. Mechanisms of dyspnea in COPD. In: Mahler DA, O'Donnell DE, eds. Dyspnea: Mechanisms, Measurement, and Management. 2nd Edn. New York, Taylor & Francis, 2005; pp. 29-58.
2. Hyatt RE. Expiratory flow limitation. J Appl Physiol 1983; 55: 1-8.
3. Dawson SV, Elliott EA. Wave-speed limitation on expiratory flow - a unifying concept. J Appl Physiol 1977; 43: 498-515.
4. Pride NB. Ageing and changes in lung mechanics. Eur Respir J 2005; 26: 563-565.
5. Pride NB, Macklem PT. Lung mechanics in disease. In: Fishman AP, ed. Handbook of Physiology, Section 3, Vol III, Part 2: The Respiratory System. Bethesda, American Physiological Society, 1986; pp. 659-692.
6. Vinegar A, Sinnett EE, Leith DE. Dynamic mechanisms determine functional residual capacity in mice Mus musculus. J Appl Physiol 1979; 46: 867-871.
7. Sharp JT. The respiratory muscles in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986; 134: 1089-1091.
8. Demedts M. Mechanisms and consequences of hyperinflation. Eur Respir J 1990; 3: 617-618.
9. Macklem PT. Hyperinflation. Am Rev Respir Dis 1984; 129: 1-2.
10. Leith DE, Brown R. Human lung volumes and the mechanisms that set them. Eur Respir J 1999; 13: 468-472.
11. Cormier Y. Mechanisms of hyperinflation in asthma. Eur Respir J 1990; 3: 619-624.
12. Martin JG. Inspiratory muscle activity during induced hyperinflation. Respir Physiol 1980; 39: 303-313.
13. Cole P, Savard P, Miljeteig H, Haight JS. Resistance to respiratory airflow of the extrapulmonary airways. Laryngoscope 1993; 103: 447-450.
14. Parker CM, Voduc N, Aaron SD, Webb KA, O'Donnell DE. Physiological changes during symptom recovery from moderate exacerbations of COPD. Eur Respir J 2005; 26: 420-428.
15. Stevenson NJ, Walker PP, Costello RW, Calverley PM. Lung mechanics and dyspnea during exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 172: 1510-1516.
16. O'Donnell DE, Parker CM. COPD exacerbations. 3. Pathophysiology. Thorax 2006; 61: 354-361.
17. O'Donnell DE, Revill S, Webb KA. Dynamic hyperinflation and exercise intolerance in COPD. Am J Respir Crit Care Med 2001; 164: 770-777.
18. Gelb AF, Guitierrez CA, Weisman IM, Newsom R, Taylor CF, Zamel N. Simplified detection of dynamic hyperinflation. Chest 2004; 126: 1855-1860.
19. O'Donnell DE, D'Arsigny C, Webb KA. Effects of hyperoxia on ventilatory limitation during exercise in advanced chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 892-898.
20. Stokes W. A treatise on the diagnosis and treatment of diseases of the chest. Part 1. Diseases of the lung and windpipe. London, The New Sydenham Society, 1837; pp. 168-169.
21. Sharp JT. The respiratory muscles in emphysema. Clin Chest Med 1983; 4: 421-432.
22. Sharp JT, Goldberg NB, Druz WS, Fishman HC, Danon J. Thoraco-abdominal motion in chronic obstructive lung disease. Am Rev Respir Dis 1977; 115: 47-56.
23. Simon G. Principles of Chest X-ray Diagnosis. 3rd Edn. London, Butterworths, 1971.
24. Simon G, Pride NB, Jones NL, Raimondi AC. Relation between abnormalities in the chest radiograph and changes in pulmonary function in chronic bronchitis and emphysema. Thorax 1973; 28: 15-23.
25. Burki NK, Krumpelman JL. Correlation of pulmonary function with the chest roentgenogram in chronic airway obstruction. Am Rev Respir Dis 1980; 121: 217-223.
26. Nakano Y, Muro S, Sakai H, et al. Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. Am J Respir Crit Care Med 2000; 162: 1102-1108.
27. de Jong PA, Müller NL, Paré PD, Coxson HO. Computed tomographic imaging of the airways: relationship to structure and function. Eur Respir J 2005; 26: 140-152.
28. Pellegrino R, Viegi G, Brusasco V, et al. ATS/ERS Task Force: Standardisation of lung function testing: Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948-968.
29. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 1993; 6: Suppl. 16, 5-40.
30. Tantucci C, Duguet A, Similowski T, Zelter M, Derenne JP, Milic-Emili J. Effect of salbutamol on dynamic hyperinflation in chronic obstructive pulmonary disease patients. Eur Respir J 1998; 12: 799-804.
31. Diaz O, Villafranca C, Ghezzo H, et al. Role of inspiratory capacity on exercise tolerance in COPD patients with and without tidal expiratory flow limitations at rest. Eur Respir J 2000; 16: 269-275.
32. Casanova C, Cote C, de Torres JP, et al. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171: 591-597.
33. O'Donnell DE, Lam M, Webb KA. Measurement of symptoms, lung hyperinflation and endurance during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158: 1557-1565.
34. O'Donnell DE, He Z, Lam M, Webb K, Fluge T, Hamilton A. Reproducibility of measurements in inspiratory capacity, dyspnea intensity and exercise endurance in multicentre trials in COPD. Eur Respir J 2004; 24: 323s.
35. O'Donnell D, Flüge T, Gerken F, et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J 2004; 23: 832-840.
36. Maltais F, Hamilton A, Marciniuk D, et al. Improvements in symptom-limited exercise performance over eight hours with once-daily Tiotropium in patients with COPD. Chest 2005; 128: 1168-1178.
37. Aliverti A, Stevenson N, Dellaca RL, Lo Mauro A, Pedotti A, Calverley PM. Regional chest wall volumes during exercise in chronic obstructive pulmonary disease. Thorax 2004; 59: 210-216.
38. Clarenbach CF, Senn O, Brack T, Kohler M, Bloch KE. Monitoring of ventilation during exercise by a portable respiratory inductive plethysmograph. Chest 2005; 128: 1282-1290.
39. Stubbing DG, Pengelly LD, Morse JLC, Jones NL. Pulmonary mechanics during exercise in subjects with chronic airflow obstruction. J Appl Physiol 1980; 49: 511-515.
40. Vogiatzis I, Georgiadou O, Golemati S, et al. Patterns of dynamic hyperinflation during exercise and recovery in patients with severe chronic obstructive pulmonary disease. Thorax 2005; 60: 723-729.
41. O'Donnell DE, Laveneziana P. The clinical importance of dynamic lung hyperinflation in COPD. COPD: Journal of Chronic Obstructive Pulmonary Disease 2006; 3: 219-232.
42. Similowski T, Yan S, Gauthier AP, Macklem PT, Bellemare F. Contractile properties of the human diaphragm during chronic hyperinflation. N Engl J Med 1991; 325: 917-923.
43. Orozco-Levi M, Gea J, Lloreta JL, et al. Subcellular adaptation of the human diaphragm in chronic obstructive pulmonary disease. Eur Respir J 1999; 13: 371-378.
44. Levine S, Kaiser L, Leferovich J, Tikunov B. Cellular adaptations in the diaphgram in chronic obstructive pulmonary disease. N Engl J Med 1997; 337: 1799-1806.
45. Mercadier JJ, Schwartz K, Schiaffino S, et al. Myosin heavy chain gene expression changes in the diaphragm of patients with chronic lung hyperinflation. Am J Physiol 1998; 274: L527-L534.
46. O'Donnell DE, Webb KA. Exercise. In: Calverley PMA, MacNee W, Pride NB, Rennard SI, eds. Chronic Obstructive Pulmonary Disease. 2nd Edn. London, Arnold, 2003; pp. 243-269.
47. O'Donnell DE, Bertley JC, Chau LK, Webb KA. Qualitative aspects of exertional breathlessness in chronic airflow limitation: pathophysiologic mechanisms. Am J Respir Crit Care Med 1997; 155: 109-115.
48. Sinderby C, Spahija J, Beck J, et al. Diaphragm activation during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 1637-1641.
49. O'Donnell DE, D'Arsigny C, Fitzpatrick M, Webb KA. Exercise hypercapnia in advanced chronic obstructive pulmonary disease: the role of lung hyperinflation. Am J Respir Crit Care Med 2002; 166: 663-668.
50. Montes de Oca M, Rassulo J, Celli BR. Respiratory muscle and cardiopulmonary function during exercise in very severe COPD. Am J Respir Crit Care Med 1996; 154: 1284-1289.
51. Light RW, Mintz WM, Linden GS, Brown SE. Hemodynamics of patients with severe chronic obstructive pulmonary disease during progressive upright exercise. Am Rev Respir Dis 1984; 130: 391-395.
52. Vizza CD, Lynch JP, Ochoa LL, Richardson G, Trulock EP. Right and left ventricular dysfunction in patients with severe pulmonary disease. Chest 1998; 113: 576-583.
53. O'Donnell DE, Hamilton AL, Webb KA. Sensory-mechanical relationships during high-intensity, constant-work-rate exercise in COPD. J Appl Physiol 2006; 101: 1025-1035.